Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

BeiGene discloses new PROTACs for cancer

Feb. 24, 2021

Researchers patent new PROTACs

Feb. 24, 2021

Targeting PI3K-driven HER2 expression in colorectal cancer stem cells

Feb. 24, 2021

Pharmaxis initiates phase I/IIa study of PXS-5505 in myelofibrosis

Feb. 23, 2021

Ascentage Pharma discovers BCR-ABL1 kinase inhibitors

Feb. 23, 2021

Zhuhai Yufan Biotechnologies presents new IRAK-4 inhibitors

Feb. 23, 2021

Promising new data from phase II advanced liver cancer study of namodenoson

Feb. 23, 2021

MediWound outlines clinical development plans for MWPC-005 in nonmelanoma skin cancer

Feb. 22, 2021

Zebrafish used to model perivascular glioblastoma multiforme invasion

Feb. 19, 2021

Phase II trial of imaging agent [64Cu]SARTATE enrolls patients with known or suspected NETs

Feb. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...